Safety of extending dosing intervals of denosumab in adults with solid cancer and bone metastasis: a review

Further RCTs with robust methodology are required to confirm the findings of this review. A large non-inferiority phase III trial is in progress, which should address this.

Authors

Institutions

Publication Details

Journal
British Journal of Nursing
Published
2026-03-05
DOI
https://doi.org/10.12968/bjon.2025.0082
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of extending dosing intervals of denosumab in adults with solid cancer and bone metastasis: a review

Emma Paul
British Journal of Nursing
Bone health and treatments
article

Safety of extending dosing intervals of denosumab in adults with solid cancer and bone metastasis: a review

Emma Paul
article en

Abstract

Further RCTs with robust methodology are required to confirm the findings of this review. A large non-inferiority phase III trial is in progress, which should address this.

British Journal of NursingVol. 35(5)
Hampshire Hospitals NHS Foundation Trust (GB)
Openalex Percentile: Top 32%
Bone health and treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety of extending dosing intervals of denosumab in adults with solid cancer and bone metastasis: a review — Emma Paul · British Journal of Nursing (2026) | TGRS Research Map | TGRS